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Abstract
Background: With fast computed tomography (CT), it is possible for the scanning to outpace the contrast medium
bolus during aortic CT angiography (CTA).
Purpose: To evaluate the effectiveness of a new method for reducing the risk of outpacing in which the scan start timing
(ST) and speed can be estimated from the peak enhancement time measured at the femoral artery using a single test-
bolus injection (femoral artery test injection method [FTI method]).
Material and Methods: In 30 cases of aortic CTA, we measured the time to peak enhancement at the femoral artery
(TPF) and the ascending aorta (TPA) with test-bolus injection performed twice in each examination. From the resultant
linear relationship between TPF and transit time (TT¼ TPF TPA), we developed a method for determining the ST and TT
from TPF. One hundred patients were assigned to two groups: FTI and bolus tracking (BT), each with 50 patients. CT
values were measured in main vessels (ascending aorta, descending aorta, femoral artery). The CT values of the vessels
and the rate of cases with more than 300 HU (good cases) were compared between the two groups.
Results: The enhancement in the FTI method was significantly higher than that of the BT method (average CT values:
FTI, 388.3 52.4; BT, 281.2 59.1; P< 0.001). The rates of good cases for FTI and BT were 86.0% and 46.0%,
respectively.
Conclusion: The FTI method was very effective in reducing the risk of outpacing of the contrast medium transit in
aortic CTA without the need for an additional contrast medium dose.
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Introduction
With multi-slice computed tomography (CT) scanners,
long-range CT scans with short scan times (high speeds)
and high longitudinal resolutions are now possible
(1–3), and the image quality of CT angiography
(CTA) by intravenous contrast medium injection has
been improved (4–7). However, it is still possible for
scanning to outpace the contrast medium bolus, espe-
cially in aortic CTA examination, before it reaches the
end point of the scan range, owing to the high-speed
nature of the scan (8,9). For such cases, the image qual-
ity of aortic CTA scans is degraded, with low
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attenuations in the aorta. It is well-known from preced-
ing studies that coexisting cardiovascular disorders and
aneurysms may slow the blood ﬂow speed in the aorta.
Thereby, in patients with such diseases, the risk of the
outpacing might be increased.
The most frequently used bolus timing techniques
are the test-bolus injection method (TI method)
(10,11) and the bolus tracking method (BT method)
(10,12–14). These methods are useful to determine the
scan delay for optimal scan start timing; however, they
cannot reduce the risk of outpacing the contrast
medium transition, because they naturally do not pro-
vide any information to optimize the scan speed corres-
ponding to the contrast medium transit time in the
aorta.
To reduce the risk of outpacing and simultaneously
obtain suﬃcient enhancement for aortic CTA, we
devised a method that enables estimation of the con-
trast medium transit time in the aorta using the peak
enhancement time at the femoral artery measured with
only one test-bolus injection (femoral artery test injec-
tion method [FTI method]). The purpose of this study
was to evaluate the eﬀectiveness of our FTI method
compared with the BT method.
Material and Methods
Pre-investigation for measuring transit time
We performed a pre-investigation directly measuring
the contrast medium transit times in the aorta by
using double test-bolus injections executed during
aortic CTA examinations. The study protocols were
approved by the local ethics board, and informed con-
sent was obtained from each participant. In the CTA
examination, the peak enhancement times at the fem-
oral artery (TPF) and the ascending aorta (TPA) were
measured with the ﬁrst test-bolus injection and subse-
quent second bolus injection, respectively, both per-
formed before the main-bolus injection (Fig. 1).
Thirty consecutive patients (19 men, 11 women;
mean age, 67.5 years; age range, 35–89 years) were
enrolled in this pre-investigation. Patient characteristics
are summarized in Table 1. In all patients, iopamidol at
a concentration of 300mg of I/mL (Iopamiron 300;
Bayer Healthcare, Osaka, Japan) was delivered via a
20-gauge catheter inserted into an antecubital vein
and a power injector (DUAL SHOT GX; Nemoto-
Kyorindo, Tokyo, Japan). Contrast material dose was
tailored to the patients’ body weight. Contrast material
volume and injection duration, respectively, were 60mg
I/kg and 3 s for the test bolus, and 300mg I/kg and 15 s
for the main angiographic bolus. With both protocols,
contrast material administration was followed by
administration of 30mL of a saline solution delivered
at the same injection rate as for the contrast material.
Fig. 1. Measurement points of TPA and TPF (times to peak enhancement at femoral artery and ascending aorta, respectively) and
examples of attenuation curves. TPF and TPA were measured in two independent test bolus monitoring procedures before the main
bolus.
Table 1. Patient characteristics of TT measurements.
Patients (n) 30
Male, female 19, 11
Age (years) 67.5 12.6
Body weight (kg) 60.6 10.7
Body height (cm) 163.3 7.7
Aortic aneurysm 9 (30%)
Aortic dissection 6 (20%)
Other (normal, post operation, including) 15 (50%)
2 Acta Radiologica 0(0)
The monitoring levels along the femoral artery and
ascending aorta were set to the levels of the pubic sym-
physis and tracheal bifurcation, respectively. All CT
scans were performed on a 64-slice CT scanner
(SOMATOM Sensation 64; Siemens Medical Systems,
Forchheim, Germany). Both monitoring scans for the
TPF and TPA measurements were performed with inter-
val scans each with 120 kV and 20 mAs, and scan start
times were set to 15 and 10 s after the beginning of the
intravenous injections, respectively. The two (right and
left) femoral and ascending aortic artery time-attenua-
tion curves were generated at circular regions of interest
(ROIs) within the respective vessels in CT images from
each patient. From the time-attenuation curves, the
TPA and TPF (average of right TPF and left TPF) were
measured, and the transit time between the ascending
aorta and femoral artery (TT) was then calculated by
TPFTPA.
Because TPA and TPF are sequential time points, if
both indicators could be measured in a single test bolus
transit, we assumed that the predicted TT, TT0 could then
be estimated from only TPF by the approximation func-
tion TT0 ¼ f (TPF), which could be estimated from the
measured relationship between TPF and TT (TPFTPA).
Fig. 2 shows plots of measured TPF versus TT in 30
aortic CTA examinations. A highly positive linear cor-
relation between TPF and TT (r¼ 0.869, P< 0.01) was
indicated. Thereby, the relationship between TPF and
TT0 was given by
TT0 ¼ 0:652TPF  5:902 ð1Þ
Thus, we assumed that the scan start timing (ST)
could also be estimated from the TPF using the follow-
ing relationship:
ST ¼ TPF  TT0 þ k ð2Þ
where k is the injection duration diﬀerence between the
test and main-boluses. According to a known relation
between the peak time and the injection duration
(15–17), the peak time depends upon the injection dur-
ation, and the longer injection duration, the more
delayed the peak time. Therefore, the true TPF for the
main-bolus is delayed by k. Because TPA was not well
correlated (r¼ 0.296, P< 0.01) with TT, as shown in
Fig. 3, we demonstrated that TPA could not be used
for the TT estimation.
Procedure for the FTI method
Fig. 4 shows the outline procedure for the FTI
method proposed in this paper. TPF was measured
by a test-bolus injection performed before the main-
bolus injection, and then TT0 and ST were calculated
using equations (1) and (2). Subsequently, the scan
time (table feed speed) for the main-bolus was
adjusted by the rotation speed and pitch factor set-
tings to agree with the calculated contrast medium
transit time. Scanning for the main-bolus was then
performed with the estimated ST and scan duration
equal to TT0.
Fig. 2. Plots of TPF versus TT (contrast medium transit time in aorta, calculated by TPF TPA) and regression line. A highly positive
correlation between TPF and TTwas indicated (P< 0.01).
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Comparison of the FTI method and the BT method
Patients: To validate the FTI method, we compared the
enhancement abilities of the FTI and BT methods,
which were used for aortic CTA examinations. One
hundred consecutive patients (39 men, 61 women;
mean age, 67 years; age range, 42–83 years) were exam-
ined. We assigned each protocol in alternating
sequence, such that every other patient (FTI method
group, 50 patients; BT method group, 50 patients)
received the same (FTI or BT) protocol. Patient char-
acteristics, including age, weight, and aortic disease for
both groups are presented in Table 2. For these patient
characteristics, no signiﬁcant diﬀerences were observed
between groups.
Parameters for investigation: Scan, reconstruction,
and contrast medium injection parameters for FTI
and BT methods are presented in Table 3. The trigger
threshold for the BT method at the ascending aorta was
set at 120 HU. The duration between the trigger and
the scan start was 5 s, equal to the time for which the
patient was instructed to hold their breath. Each con-
trast medium administration was followed by 30mL of
saline solution at the same injection rate as for the con-
trast material.
Fig. 3. Plots of TPA versus TT and regression line. TPA was not well correlated with TT.
Fig. 4. Outline procedure of FTI method.
Table 2. Patient backgrounds of the FTI and BT method
groups.
FTI method BT method
Patients (n) 50 50
Male, female 21, 29 18, 32
Age (years) 69.5 10.2 66.2 9.4
Body weight (kg) 62.1 10.6 61.2 8.8
Body height (cm) 159.9 8.9 160.9 7.1
Aortic aneurysm 14 (28%) 16 (32%)
Aortic dissection 20 (40%) 20 (40%)
Other diseases (including normal) 16 (32%) 14 (28%)
4 Acta Radiologica 0(0)
As the injection durations of the test and main-
boluses for the FTI method were 3 s and 15 s, respect-
ively, the k-factor in the equation (2) was set to 12
(153). The range between levels of the sternoclavicu-
lar joint (superior margin of aortic arch) and the upper
edge of the pubic symphysis was scanned in the cranio-
caudal direction for each main-bolus injection.
The ranges of pitch factor and rotation time used for
the FTI method were 0.45–1.5 and 0.33–1.0, respect-
ively. In cases where the scan duration was not able
to be precisely adjusted to TT0, the scan duration was
set to the nearest value larger than TT0.
Assessment of contrast enhancement: Arterial CT
values for contrast enhancement were measured for
each patient. ROIs were placed in the ascending aorta
at the level of the tracheal branch (AAo), at the descend-
ing aorta at the level of the ﬁrst lumbar vertebra (DAo),
and in the right and left femoral arteries at the level of
the pubic symphysis. The two ROI values in the femoral
arteries were averaged into one ROI value (FA). Cases
in which the CT values of all of the three ROIs were 300
HU or greater were classiﬁed as ‘‘good cases’’, because
an aorta enhancement of 300 HU or higher is required if
aortic side branches are to be visualized (18). Thus, cases
with CT values less than 300 HU in at least one ROI
were classiﬁed as ‘‘poor cases’’. Signiﬁcance diﬀerences
between the FTI and BT methods were evaluated with
the Mann-Whitney U test at P< 0.01. SPSS version 11
software (IBM Corporation, Armonk, NY, USA) was
used for the statistical analysis.
Results
Fig. 5 shows box plots of mean CT values over the
three ROIs (AAo, DAo, and FA) for the FTI and BT
methods. The all-mean CT value of the FTI method
was signiﬁcantly higher than that of the BT method
(388.3 52.4 HU for the FTI method and
281.2 59.1 HU for the BT method, P< 0.001). The
mean CT values for the three ROIs presented in
Table 4 also indicated signiﬁcant improvements with
the FTI method (P< 0.05). Though no signiﬁcant CT
value diﬀerences between the three ROIs were observed
in both methods (P> 0.05), the FA/CT value drop
Table 3. Scan, reconstruction, and contrast medium injection parameters for FTI and BT method.
FTI method BT method
Test bolus scan Main scan Monitoring scan Main scan
Tube voltage (kV) 120 120 120 120
Reference mAs * 20 200 20 200
Rotation time (s/rot.) 0.5 Variable (0.33–1.0) 0.5 0.5
Scan delay time (s) 15 Variable 10 Variable
Detector configuration 1 5mm 64 0.6mm 1 5mm 64 0.6mm
Pitch factor NA Variable (0.45–1.5) NA 1.0
Slice thickness 5.0 5.0 5.0 5.0
Reconstruction kernel B31f B31f B31f B31f
CM concentration (mgI/mL) 300 300 300 300
CM dose (mgI/kg) 60 300 NA 300
Injection duration (s) 3 15 NA 15
*mAs setting of CT automatic exposure control system.
CM, contrast medium; NA, not applicable.
Fig. 5. Box plots of mean CT values over three ROIs (AAo,
DAo, and FA) for FTI methods.
Table 4. Means and standard deviations of CT values of three
ROIs for FTI and BT methods.
FTI method BT method P value
Ascending aorta (HU) 391.7 58.6 299.7 64.1 <0.05
Descending aorta (HU) 399.5 51.0 285.7 64.5 <0.05
Femoral artery (HU) 373.8 56.4 258.2 75.1 <0.05
Hoshino et al. 5
from AAo of the BT method (13.9%) was higher than
that of the FTI group (4.6%). Fig. 6 represents the
maximum intensity projection image examples for the
good and poor cases, respectively. In the poor cases in
the FTI method, though the enhancement at the
ascending aorta was not suﬃcient, as shown in
Fig. 6c, the mean CT value for the group of 279 HU
was close to the minimum threshold level for a ‘‘good
case’’ (300 HU). Especially in the poor cases using the
BT method, enhancement diﬀerences between the
upper and lower regions of the aorta due to outpacing
of the CT scan were notable. Table 5 provides means
and standard deviations of the CT values of the three
ROIs, scan start times, and scan durations for good
cases and poor cases using the FTI method. From the
suﬃcient ROI values at the femoral artery, we found
that the outpacing problem for aortic CTA was mostly
overcome, even for the poor cases. The scan start
timings and scan durations of the poor cases were sig-
niﬁcantly delayed and longer, respectively, compared
with those of the good cases (P< 0.01 for both).
Rates of ‘‘good cases’’ for the FTI and BT methods
were 86.0% and 46.0%, respectively. The mean CT
values of the good cases in the BT group and the
poor cases in the FTI group were 340.66 25.69 HU
and 342.51 22.66 HU, respectively, and there were no
signiﬁcant diﬀerences between them (P¼ 0.916).
Discussion
The extent of this type of CT examination is very long,
and the contrast medium bolus transit speed is very
variable among individuals. According to a report by
Fleischmann and Rubin, transit speeds between the
aorta and popliteal artery were in the range of
29–177mm/s for patients with peripheral arterial occlu-
sive disease (PAOD), who potentially have a lower
blood ﬂow speed than normal patients (8). Nakaya
et al. also reported that aorto-popliteal bolus transit
speeds for 42 patients with vascular diseases such as
PAOD, abdominal aortic aneurysm, and aortitis were
in the range of 34.2–136.7mm/s (9). Scan speeds of
current clinical scanners with 64–128 detector-rows
(32–80mm detector full widths) were in the range of
approximately 50–130mm/s with assumed conditions
of a pitch factor of 0.8 and a rotation speed of 0.5 s.
Assuming that the speed range in the region of aortic
CTA (longitudinal range: just above the aortic arch to
the femoral heads) is similar to that of aorto-popliteal
Fig. 6. Maximum intensity projection image examples of good cases for (a) FTI method and (b) BT method; poor cases for (c) FTI
method and (d) BT method. Respective scan start times/scan durations (s) were (a) 34.0/30.1, (b) 25.0/9.3, (c) 27.0/30.2, and,
(d) 35.0/17.8.
Table 5. Means and standard deviations of CT values for good
cases and poor cases in FTI method.
Good case Poor case P value
Ascending aorta (HU) 404.3 59.9 289.7 7.1 <0.01
Descending aorta (HU) 386.6 53.9 342.2 36.5 <0.05
Femoral artery (HU) 376.4 54.9 357.2 44.5 0.22
Scan start time (s) 28.4 1.9 36.9 3.8 <0.01
Scan duration (s) 13.7 3.6 29.6 7.1 <0.01
6 Acta Radiologica 0(0)
bolus transit, the possibility for current MSCT scanners
outpacing the contrast medium transit in aortic CTA
also then becomes higher with increases in scan speeds.
To reduce the risk of outpacing, Fleischmann and
Rubin proposed a method with extended injection dur-
ation, combined with a reduction in acquisition speed
or an increased scanning delay (8). This method might
impair the contrast medium dose saving, maintaining
suﬃcient enhancement, which is one of the features of
the current high-speed MSCT systems, because an
increase in the contrast medium dose is unavoidable
in this approach. Therefore, even if the extension of
injection duration combined with the delayed scan
start is eﬀective to reduce the risk of outpacing, the
increase in contrast medium dose is problematic in
terms of the risk of renal dysfunction caused by the
contrast medium injection (19–21).
One option to cope with this problem would be to
measure ascending aorta and femoral artery arrival
times in every individual and to adjust the acquisition
speed according to the TT estimated by the two mea-
sured arrival times. Laswed et al. measured the aorto-
popliteal bolus transit speed by using a single test-bolus
injection and two sequential low-dose dynamic acquisi-
tions, and the CTA scan speed was optimized using the
estimated TT (22). However, quick table transition and
scan preparation between the ascending aorta and fem-
oral artery may not be possible depending on the
MSCT system. Because the estimated transit speed in
the aorta measured in our investigation was in the
range of 12.8–82.1mm/s, the scan speed could be suc-
cessfully adjusted to achieve the desired scan duration
with a reasonable pitch factor range (0.45–1.5) and
rotation time range (0.33–1.0 s) for the MSCT system
we used. As the maximum speed of 177mm/s reported
by Fleischmann and Rubin was impossible for our
MSCT system, with a maximum speed of 87.3mm/s,
for cases with such high transit speeds, longer injection
durations might be needed to achieve suﬃcient
enhancement. Thus, increases in contrast medium
dose are unavoidable in such cases. However, as the
maximum scan speeds of recent 64-slice MSCT systems
with 40-mm detector full widths, which are becoming
more widespread, reach approximately 180mm/s, the
FTI-method can be safely performed without increas-
ing contrast medium dose using such MSCT systems.
In all of the poor contrast enhancement cases
(7 cases) for the FTI method, the ROI values at the
ascending aorta were less than 300HU
(289.7 7.1HU), while other ROIs in all cases pre-
sented suﬃcient values more than 300HU (DAo
range, 302.5–398.1HU; FA range, 309.4–448.3HU).
The average TT of poor cases with the FTI method
was 29.6 7.1 s, which is much longer than the
13.7 3.6 s of good cases, as shown in Table 5. Thus,
the diﬀerence between the actual scan timing at the
ascending aorta and the estimated ST became longer
in all poor cases. To prevent this problem, the injection
duration should be prolonged according to the scan
timing diﬀerence between the upper edge of the aortic
arch and the lower ascending aorta. In this study, we
used the contrast medium at low concentrations
(300mg I/mL). Thus, the use of higher concentrations
might aﬀect the results of our study. However, it seems
that the signiﬁcantly low CT values (minimum of
60.6HU) at the femoral arteries in the poor cases of
BT method would not be improved to more than
300HU even by using higher concentrations.
The FTI method has some drawbacks. This method
cannot be applied to patients with bilateral complete
occlusions of the femoral arteries due to diseases such
as arteriosclerosis obliterans or aortic dissection invol-
ving femoral arteries. Moreover, in cases of short TT,
the corresponding high scan speeds may require higher
pitch factors which can address the deterioration of
image quality (23,24). However because the 64-slice
MSCT systems with 40-mm detector full widths,
which are wider than that of the MSCT we used in
this study, are becoming standard, it is possible to
manage the fast blood ﬂow without using excessive
pitch factors that cause image quality deterioration.
Our study had several limitations. First, the number
and selection of participants in our study population
may not have ensured that it was representative of
the entire population of patients with aortic disease.
Moreover, though the FTI method requires only one
time test-bolus monitoring, the procedures in this
method may not be simple in that the peak time meas-
urement at the femoral artery, estimation of the ST
(TT0), and scan speed adjustment are needed before
main-bolus scanning.
In conclusion, the FTI method, which can determine
the correct scan start timing and speed for aortic CTA
from only a single test-bolus monitoring at the femoral
artery, was very eﬀective for reducing the risk of con-
trast medium transit outpacing and simultaneously
improving contrast enhancement without the need for
an additional radiation dose compared with the BT and
TI methods.
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